Funder
Gouvernement du Canada | Canadian Institutes of Health Research
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. DeGeorge, K. C., Holt, H. R. & Hodges, S. C. Bladder Cancer: Diagnosis and Treatment. Am Fam Physician 96, 507–514 (2017).
2. Ries Lag, Y. J., Keel, G. E., Eisner, M. P., Lin, Y. D. & Horner, M.-J. SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988–2001, Patient and Tumor Characteristics. National Cancer Institute (2007).
3. Shabsigh, A. et al. Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology. European Urology 55, 164–176,
https://doi.org/10.1016/j.eururo.2008.07.031
(2009).
4. Giacalone, N. J. et al. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience. European Urology 71, 952–960,
https://doi.org/10.1016/j.eururo.2016.12.020
(2017).
5. James, N. D. et al. Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer. New England Journal of Medicine 366, 1477–1488,
https://doi.org/10.1056/NEJMoa1106106
(2012).
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献